Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study

PURPOSE: The objective of this study was to assess preference for fixed-combination brinzolamide 1%/timolol 0.5% (BTFC) versus fixed-combination dorzolamide 2%/timolol 0.5% (DTFC) in patients with open-angle glaucoma or ocular hypertension. METHODS: In this prospective, single-masked crossover study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Ophthalmol
Autors principals: Altafini, Romeo, Scherzer, Maria-Luise, Hubatsch, Douglas A, Frezzotti, Paolo
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4671806/
https://ncbi.nlm.nih.gov/pubmed/26664041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S88891
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars